RecruitingNCT02979951

Fosfomycin I.v. for Treatment of Severely Infected Patients

Studying Brain inflammatory disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Infectopharm Arzneimittel GmbH
Principal Investigator
Klaus-Friedrich Bodmann, Dr.
Klinik Nordoberpfalz AG, Klinikum Weiden
Enrollment
1000 enrolled
Eligibility
18 years · All sexes
Timeline
20162030

Study locations (30)

Collaborators

INPADS GmbH · Dr. Oestreich + Partner GmbH

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02979951 on ClinicalTrials.gov

Other trials for Brain inflammatory disease

Additional recruiting or active studies for the same condition.

See all trials for Brain inflammatory disease

← Back to all trials